Frank Rimerman Advisors’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$371K Buy
9,476
+160
+2% +$5.94K 0.02% 468
2026
Q1
$373K Buy
+9,316
New +$441K 0.02% 439
2025
Q4
Sell
-9,807
Closed -$438K 635
2025
Q3
$438K Hold
9,807
0.03% 398
2025
Q2
$471K Hold
9,807
0.03% 361
2025
Q1
$394K Sell
9,807
-2
-0% -$84 0.03% 359
2024
Q4
$449K Hold
9,809
0.03% 330
2024
Q3
$460K Hold
9,809
0.03% 342
2024
Q2
$415K Buy
+9,809
New +$430K 0.03% 378

Other funds holding QGEN

Frank Rimerman Advisors's QGEN Position: Q2 2026 in Review

Frank Rimerman Advisors increased its Qiagen (QGEN) stake by 1.7% in Q2 2026, buying an estimated $5.94K and bringing the position to 9,476 shares worth $371K. The position accounts for 0.02% of the portfolio, ranked #468.

Frank Rimerman Advisors first reported a position in QGEN in Q2 2024 and has held it in 8 quarters since. The position peaked at $471K in Q2 2025. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • Frank Rimerman Advisors held 9,476 shares of Qiagen worth $371K as of Q2 2026.
  • Frank Rimerman Advisors bought 160 Qiagen shares in Q2 2026, an estimated $5.94K.
  • Qiagen made up 0.02% of Frank Rimerman Advisors's portfolio in Q2 2026, its #468 holding.
  • Frank Rimerman Advisors first reported a position in Qiagen in Q2 2024 and has held it in 8 quarters since.
  • Frank Rimerman Advisors's Qiagen position peaked at $471K in Q2 2025.
  • 336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Frank Rimerman Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.